ESOMEPRAZOLE MAGNESIUM
- Product NDC
- 69097-527
- 11-digit product format
- 690970527
- Labeler code
- 69097
- Product ID
- 69097-527_95dea6c3-8880-42b2-a2d4-8cf93629127e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ESOMEPRAZOLE MAGNESIUM
- Dosage form
- GRANULE, FOR SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA211752
- Marketing category
- ANDA
- Marketing start
- 2020-03-24
- Substance
- ESOMEPRAZOLE MAGNESIUM
- Active strength
- 10 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ESOMEPRAZOLE MAGNESIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ESOMEPRAZOLE MAGNESIUM | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | R6DXU4WAY9 |
| Rxcui | 861568 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-527-34 | ESOMEPRAZOLE MAGNESIUM | 30 in 1 CARTON | GRANULE, FOR SUSPENSION, EXTENDE | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-527 | ESOMEPRAZOLE MAGNESIUM GRANULE, FOR SUSPENSION, EXTENDED RELEASE [CIPLA USA INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240517_180490d1-c165-4bb9-96b1-12e727256e4e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-527-34 | 69097052734 | 30 GRANULE, FOR SUSPENSION, EXTENDED RELEASE in 1 CARTON (69097-527-34) | 2020-03-24 | 0000-00-00 | No | No | Current |